Issue |
J Extra Corpor Technol
Volume 56, Number 3, September 2024
|
|
---|---|---|
Page(s) | 125 - 127 | |
DOI | https://doi.org/10.1051/ject/2024021 | |
Published online | 20 September 2024 |
Case Report
Cardiopulmonary bypass in a pediatric patient with factor XII deficiency
Children's Hospital Los Angeles, 4650 Sunset Blvd, Los Angeles, CA 90027, USA
* Corresponding author: julie.fenske@med.usc.edu
Received:
10
April
2024
Accepted:
22
July
2024
The safe use of cardiopulmonary bypass (CPB) relies upon the ability to administer, monitor, and reverse anticoagulation. Although rare, the factor XII deficient patient creates a challenge for the perfusionist due to resultant complications in monitoring anticoagulation. There have been proposed strategies to aid in monitoring anticoagulation in factor XII deficient patients, however, documentation of successful monitoring during CPB is infrequent. With the use of the Hemochron Signature Elite and ACT + cartridges, CPB in a factor XII deficient 8-month-old was completed with predictable and reliable anticoagulation monitoring. This case report explores the current suggestions for factor XII deficiency management with CPB.
Key words: Cardiopulmonary bypass / Perfusion / Factor XII / Deficiency / Coagulopathy / Anticoagulation / Pediatrics
© The Author(s), published by EDP Sciences, 2024
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.